| Disease | Micro RNA | Tissue/ Cell line | MicroRNA regulation | Targeted Member | More Details | References |
|---|---|---|---|---|---|---|
| Triple negative breast cancer | hsa-miR-200b | MCF-7, MDA-MB-231, MDA-MB-157 | MicroRNA-200b inhibits the RhoGDI pathway, which leads to non-canonical suppression of epithelial-to-mesenchymal transition in triple-negative breast cancer. | Rhodes et al., 2015 | ||
| Triple negative breast cancer | hsa-miR-200b | MCF-7, MDA-MB-231, MDA-MB-157 | MicroRNA-200b inhibits the RhoGDI pathway, which leads to non-canonical suppression of epithelial-to-mesenchymal transition in triple-negative breast cancer. | Rhodes et al., 2015 |